Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions

Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

admin.veranex

Dasiglucagon Demonstrates Reduced Costs in the Treatment of Severe Hypoglycemia in a Budget Impact Model

admin.veranex: Mar 24, 2025 10:22:50 PM

Jordan Hinahara and Thomas Goss, members of our Commercial Strategy and Market Access team, contributed to the budget impact model. The objective was to evaluate the economic impact of dasiglucagon compared with available glucagon treatments for SHE...

Commercialization
Read More

Regulatory Affairs and Quality Management Sales Sheet

admin.veranex: Mar 24, 2025 10:22:50 PM

Fullscreen Mode

Read More

Clinical Development Services Sales Sheet

admin.veranex: Mar 24, 2025 10:22:50 PM

Fullscreen Mode

Device CRO
Read More

What differentiates us? It’s our people

admin.veranex: Mar 24, 2025 10:22:50 PM

Hear from Brian Loushine and why our people can create great outcomes.

Read More

Digital Healthcare:  To Discovery and Beyond

admin.veranex: Mar 24, 2025 10:22:49 PM

We recently sat down with Gary Keeler, Director of Digital Experiences and subject matter expert, to discuss the vast opportunities that exist in the...

Read More

Veranex Presents Study Results at the National Kidney Foundation Spring Clinical Meeting

admin.veranex: Mar 24, 2025 10:22:49 PM

Dr. Manasi Datar and colleagues used conjoint analysis to estimate preferences regarding kidney disease testing from 401 PCPs via a web survey....

Commercialization
Read More

One Minute With the Expert

admin.veranex: Mar 24, 2025 10:22:49 PM

We sat down with Dr. Olivier Chevènement, DVM, PhD, Veterinary Surgeon and Study Director at Veranex to discuss comparative anatomy of the tricuspid...

Read More

Product Design and Engineering Sales Sheet

admin.veranex: Mar 24, 2025 10:22:49 PM

Fullscreen Mode

Read More

Veranex Supports Retrospective Claims Analysis of Physical Therapy Utilization Among Women With Stress or Mixed Urinary Incontinence

admin.veranex: Mar 24, 2025 10:22:49 PM

Manasi Datar, Li-Chen Pan, and Thomas Goss, members of the Veranex Commercial Strategy and Market Access team, supported the retrospective claims...

Commercialization
Read More

Digital Experiences for the Sandwich Generation

admin.veranex: Mar 24, 2025 10:22:47 PM

[dpvfw_pdf_viewer_embed pdfviewer=”2954″ zoom_pdf=”page-fit” _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″...

Read More
Prev 4 5 6 7 8 Next